The Bovhyaluronidase Azoximer (Longidaza<sup>®</sup>) Disrupts <i>Candida albicans</i> and <i>Candida albicans</i>-Bacterial Mixed Biofilms and Increases the Efficacy of Antifungals
<i>Background and Objectives: Candida albicans</i> causes various diseases ranging from superficial mycoses to life-threatening systemic infections often associated with biofilm formation, including mixed fungal–bacterial consortia. The biofilm matrix protects cells, making <i>Cand...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/12/1710 |